Mechanism of action of trastuzumab and scientific update

被引：76

作者：

Baselga, J ^{[1
]}

Albanell, J ^{[1
]}

Molina, MA ^{[1
]}

Arribas, J ^{[1
]}

机构：

[1] Univ Barcelona, Hosp Gen Valle Hebron, Med Oncol Serv, Barcelona 08035, Spain

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 05期

关键词：

D O I：

10.1016/S0093-7754(01)90276-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4 / 11

页数：8

共 32 条

[1] THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN [J].

BARGMANN, CI ;

HUNG, MC ;

WEINBERG, RA .

NATURE, 1986, 319 (6050) :226-230

[2]

Baselga J, 1999, SEMIN ONCOL, V26, P78

[3] Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].

Baselga, J ;

Tripathy, D ;

Mendelsohn, J ;

Baughman, S ;

Benz, CC ;

Dantis, L ;

Sklarin, NT ;

Seidman, AD ;

Hudis, CA ;

Moore, J ;

Rosen, PP ;

Twaddell, T ;

Henderson, IC ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744

[4]

Brodowicz T, 1997, INT J CANCER, V73, P875, DOI 10.1002/(SICI)1097-0215(19971210)73:6<875::AID-IJC19>3.0.CO

[5]

2-3

[6] HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J].

CARTER, P ;

PRESTA, L ;

GORMAN, CM ;

RIDGWAY, JBB ;

HENNER, D ;

WONG, WLT ;

ROWLAND, AM ;

KOTTS, C ;

CARVER, ME ;

SHEPARD, HM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4285-4289

[7] Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].

Clynes, RA ;

Towers, TL ;

Presta, LG ;

Ravetch, JV .

NATURE MEDICINE, 2000, 6 (04) :443-446

[8]

CONDONYSERVAT J, 1999, CANCER RES, V59, P1196

[9] TYROSINE KINASE RECEPTOR WITH EXTENSIVE HOMOLOGY TO EGF RECEPTOR SHARES CHROMOSOMAL LOCATION WITH NEU ONCOGENE [J].

COUSSENS, L ;

YANGFENG, TL ;

LIAO, YC ;

CHEN, E ;

GRAY, A ;

MCGRATH, J ;

SEEBURG, PH ;

LIBERMANN, TA ;

SCHLESSINGER, J ;

FRANCKE, U ;

LEVINSON, A ;

ULLRICH, A .

SCIENCE, 1985, 230 (4730) :1132-1139

[10] ERBB-2 IS A POTENT ONCOGENE WHEN OVEREXPRESSED IN NIH/3T3 CELLS [J].

DIFIORE, PP ;

PIERCE, JH ;

KRAUS, MH ;

SEGATTO, O ;

KING, CR ;

AARONSON, SA .

SCIENCE, 1987, 237 (4811) :178-182

← 1 2 3 4 →